Cargando…

A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis

RATIONALE: Neutrophil extracellular traps (NETs) are immune defence systems that release extracellular chromatin and myeloid granules including myeloperoxidase (MPO) to kill pathogens. An experimental animal study recently demonstrated that disordered NETs induced by propylthiouracil (PTU) could con...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe-Kusunoki, Kanako, Abe, Nobuya, Nakazawa, Daigo, Karino, Kohei, Hattanda, Fumihiko, Fujieda, Yuichiro, Nishio, Saori, Yasuda, Shinsuke, Ishizu, Akihiro, Atsumi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831184/
https://www.ncbi.nlm.nih.gov/pubmed/31027105
http://dx.doi.org/10.1097/MD.0000000000015328
_version_ 1783465910201221120
author Watanabe-Kusunoki, Kanako
Abe, Nobuya
Nakazawa, Daigo
Karino, Kohei
Hattanda, Fumihiko
Fujieda, Yuichiro
Nishio, Saori
Yasuda, Shinsuke
Ishizu, Akihiro
Atsumi, Tatsuya
author_facet Watanabe-Kusunoki, Kanako
Abe, Nobuya
Nakazawa, Daigo
Karino, Kohei
Hattanda, Fumihiko
Fujieda, Yuichiro
Nishio, Saori
Yasuda, Shinsuke
Ishizu, Akihiro
Atsumi, Tatsuya
author_sort Watanabe-Kusunoki, Kanako
collection PubMed
description RATIONALE: Neutrophil extracellular traps (NETs) are immune defence systems that release extracellular chromatin and myeloid granules including myeloperoxidase (MPO) to kill pathogens. An experimental animal study recently demonstrated that disordered NETs induced by propylthiouracil (PTU) could contribute to the production of MPO anti-neutrophil cytoplasmic antibody (ANCA) and the development of ANCA-associated vasculitis (AAV). However, the role of dysregulated NETs in the pathogenesis of human AAV remains unclear. PATIENT CONCERNS: We report a 19-year-old woman with Graves’ disease on PTU presented fever, polyarthralgia, and lung hemorrhage with high titer of MPO-ANCA. This patient had a variety of atypical ANCAs and disordered NETs in vitro. DIAGNOSES: A diagnosis of PTU-induced AAV (PTU-AAV). INTERVENTIONS: The PTU was discontinued and she was treated with immunosuppressants and plasmapheresis for reducing pathogenic autoantibodies. OUTCOMES: Clinical manifestations including fever, polyarthralgia, and lung hemorrhage were on remission with a decrease of dysregulated NETs. LESSONS: The clinical course of this PTU-AAV case indicated that dysregulated NETs would play a role in the development of ANCA and the pathogenesis of AAV.
format Online
Article
Text
id pubmed-6831184
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-68311842019-11-19 A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis Watanabe-Kusunoki, Kanako Abe, Nobuya Nakazawa, Daigo Karino, Kohei Hattanda, Fumihiko Fujieda, Yuichiro Nishio, Saori Yasuda, Shinsuke Ishizu, Akihiro Atsumi, Tatsuya Medicine (Baltimore) 3600 RATIONALE: Neutrophil extracellular traps (NETs) are immune defence systems that release extracellular chromatin and myeloid granules including myeloperoxidase (MPO) to kill pathogens. An experimental animal study recently demonstrated that disordered NETs induced by propylthiouracil (PTU) could contribute to the production of MPO anti-neutrophil cytoplasmic antibody (ANCA) and the development of ANCA-associated vasculitis (AAV). However, the role of dysregulated NETs in the pathogenesis of human AAV remains unclear. PATIENT CONCERNS: We report a 19-year-old woman with Graves’ disease on PTU presented fever, polyarthralgia, and lung hemorrhage with high titer of MPO-ANCA. This patient had a variety of atypical ANCAs and disordered NETs in vitro. DIAGNOSES: A diagnosis of PTU-induced AAV (PTU-AAV). INTERVENTIONS: The PTU was discontinued and she was treated with immunosuppressants and plasmapheresis for reducing pathogenic autoantibodies. OUTCOMES: Clinical manifestations including fever, polyarthralgia, and lung hemorrhage were on remission with a decrease of dysregulated NETs. LESSONS: The clinical course of this PTU-AAV case indicated that dysregulated NETs would play a role in the development of ANCA and the pathogenesis of AAV. Wolters Kluwer Health 2019-04-26 /pmc/articles/PMC6831184/ /pubmed/31027105 http://dx.doi.org/10.1097/MD.0000000000015328 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3600
Watanabe-Kusunoki, Kanako
Abe, Nobuya
Nakazawa, Daigo
Karino, Kohei
Hattanda, Fumihiko
Fujieda, Yuichiro
Nishio, Saori
Yasuda, Shinsuke
Ishizu, Akihiro
Atsumi, Tatsuya
A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
title A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
title_full A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
title_fullStr A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
title_full_unstemmed A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
title_short A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
title_sort case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
topic 3600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831184/
https://www.ncbi.nlm.nih.gov/pubmed/31027105
http://dx.doi.org/10.1097/MD.0000000000015328
work_keys_str_mv AT watanabekusunokikanako acasereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT abenobuya acasereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT nakazawadaigo acasereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT karinokohei acasereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT hattandafumihiko acasereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT fujiedayuichiro acasereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT nishiosaori acasereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT yasudashinsuke acasereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT ishizuakihiro acasereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT atsumitatsuya acasereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT watanabekusunokikanako casereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT abenobuya casereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT nakazawadaigo casereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT karinokohei casereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT hattandafumihiko casereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT fujiedayuichiro casereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT nishiosaori casereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT yasudashinsuke casereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT ishizuakihiro casereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT atsumitatsuya casereportdysregulatedneutrophilextracellulartrapsinapatientwithpropylthiouracilinducedantineutrophilcytoplasmicantibodyassociatedvasculitis